NZ599171A - Sulfonamides for the prevention of diabetes - Google Patents

Sulfonamides for the prevention of diabetes

Info

Publication number
NZ599171A
NZ599171A NZ599171A NZ59917110A NZ599171A NZ 599171 A NZ599171 A NZ 599171A NZ 599171 A NZ599171 A NZ 599171A NZ 59917110 A NZ59917110 A NZ 59917110A NZ 599171 A NZ599171 A NZ 599171A
Authority
NZ
New Zealand
Prior art keywords
diabetes
sulfonamides
prevention
disclosed
medicaments
Prior art date
Application number
NZ599171A
Other languages
English (en)
Inventor
Luisa Daffonchio
Lorenzo Piemonti
Marcello Allegretti
Original Assignee
Dompe Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompe Spa filed Critical Dompe Spa
Publication of NZ599171A publication Critical patent/NZ599171A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/51—Y being a hydrogen or a carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NZ599171A 2009-10-06 2010-10-06 Sulfonamides for the prevention of diabetes NZ599171A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09172365A EP2308485A1 (en) 2009-10-06 2009-10-06 Sulfonamides for the prevention of diabetes
PCT/EP2010/064920 WO2011042465A1 (en) 2009-10-06 2010-10-06 Sulfonamides for the prevention of diabetes

Publications (1)

Publication Number Publication Date
NZ599171A true NZ599171A (en) 2014-03-28

Family

ID=41716341

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ599171A NZ599171A (en) 2009-10-06 2010-10-06 Sulfonamides for the prevention of diabetes

Country Status (24)

Country Link
US (2) US8846755B2 (https=)
EP (2) EP2308485A1 (https=)
JP (1) JP5745526B2 (https=)
KR (1) KR101737656B1 (https=)
CN (1) CN102639128B (https=)
AU (1) AU2010305384B2 (https=)
BR (1) BR112012007989B1 (https=)
CA (1) CA2776021C (https=)
CY (1) CY1117599T1 (https=)
DK (1) DK2485724T3 (https=)
EA (1) EA021788B1 (https=)
ES (1) ES2570463T3 (https=)
HR (1) HRP20160399T1 (https=)
HU (1) HUE028132T2 (https=)
IL (1) IL219038A (https=)
ME (1) ME02385B (https=)
MX (1) MX2012004087A (https=)
NZ (1) NZ599171A (https=)
PL (1) PL2485724T3 (https=)
RS (1) RS54693B1 (https=)
SI (1) SI2485724T1 (https=)
SM (1) SMT201600126B (https=)
WO (1) WO2011042465A1 (https=)
ZA (1) ZA201202462B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9844528B2 (en) * 2006-08-24 2017-12-19 University Of Tennessee Research Foundation SARMs and method of use thereof
EP2308485A1 (en) 2009-10-06 2011-04-13 Dompé S.p.a. Sulfonamides for the prevention of diabetes
EP3281937A1 (en) * 2016-08-09 2018-02-14 Dompé farmaceutici S.p.A. Sulfonamides as gpr40- and gpr120-agonists
US11291641B2 (en) 2016-10-03 2022-04-05 The Children's Medical Center Corporation Prevention and treatment of diabetic nephropathy
EP4686469A1 (en) 2024-07-31 2026-02-04 Dompé farmaceutici SpA Cxcl8 inhibitors for use in the treatment of diabetes-associated comorbidities

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1303249B1 (it) * 1998-10-23 2000-11-06 Dompe Spa Alcune n-(2-aril-propionil)-solfonammidi e preparazionifarmaceutiche che le contengono.
ITMI20010206A1 (it) * 2001-02-02 2002-08-02 Dompe Spa Uso della metansolfonammide di (r)-ibuprofene e dei suoi sali non tossici per la preparazione di medicamenti per il trattamento e la prevenz
US20040242498A1 (en) * 2003-02-27 2004-12-02 Collins Tassie L. CXCR3 antagonists
ATE444286T1 (de) 2004-03-23 2009-10-15 Dompe Pha R Ma Spa Res & Mfg 2-phenylpropionsäurederivate und diese enthaltende pharmazeutische zusammensetzung
PT1579859E (pt) 2004-03-25 2007-03-30 Dompe Pha R Ma Spa Res & Mfg Utilização de n-(2-aril-propionil)-sulfonamidas pata o tratamento de lesões da medula espinal
CN102088993A (zh) * 2008-03-20 2011-06-08 卡罗勒斯治疗公司 炎症的治疗方法
EP2308484A1 (en) * 2009-10-06 2011-04-13 Dompé S.p.a. Inhibitors of cxcr1/2 as adjuvants in the transplant of pancreatic islets
EP2308485A1 (en) 2009-10-06 2011-04-13 Dompé S.p.a. Sulfonamides for the prevention of diabetes

Also Published As

Publication number Publication date
IL219038A (en) 2015-07-30
HRP20160399T1 (hr) 2016-05-20
US8846755B2 (en) 2014-09-30
AU2010305384B2 (en) 2016-02-04
CN102639128A (zh) 2012-08-15
IL219038A0 (en) 2012-06-28
JP5745526B2 (ja) 2015-07-08
HUE028132T2 (en) 2016-11-28
KR20120083889A (ko) 2012-07-26
CY1117599T1 (el) 2017-04-26
US20130059908A1 (en) 2013-03-07
JP2013506703A (ja) 2013-02-28
DK2485724T3 (en) 2016-05-02
EA021788B1 (ru) 2015-08-31
PL2485724T3 (pl) 2016-07-29
CA2776021C (en) 2017-08-01
BR112012007989B1 (pt) 2019-10-22
US9556115B2 (en) 2017-01-31
WO2011042465A1 (en) 2011-04-14
US20150011639A1 (en) 2015-01-08
KR101737656B1 (ko) 2017-05-18
ZA201202462B (en) 2013-06-26
AU2010305384A1 (en) 2012-04-26
RS54693B1 (sr) 2016-08-31
HK1174557A1 (en) 2013-06-14
EP2485724B1 (en) 2016-02-10
CA2776021A1 (en) 2011-04-14
SMT201600126B (it) 2016-07-01
ME02385B (me) 2016-09-20
EA201270512A1 (ru) 2012-11-30
SI2485724T1 (sl) 2018-12-31
MX2012004087A (es) 2012-08-23
ES2570463T3 (es) 2016-05-18
EP2308485A1 (en) 2011-04-13
CN102639128B (zh) 2014-02-26
EP2485724A1 (en) 2012-08-15

Similar Documents

Publication Publication Date Title
IN2012DN01233A (https=)
MX2011011854A (es) Dihidropirimidinonas para uso como inhibidores de la bace2.
WO2008011130A3 (en) Amide compounds
WO2008011131A3 (en) Amide compounds
WO2007125103A3 (en) Benzamide glucokinase activators
MX2013001204A (es) Compuesto para el tratamiento/prevencion de enfermedades inflamatorias oculares.
MX336381B (es) Boronatos como inhibidores de arginasa.
WO2011056985A3 (en) Substituted heterocyclic compounds
MX2012002633A (es) Aminotetrahidropiranos como inhibidores de la dipeptidil peptidasa iv para el tratamiento prevencion de la diabetes.
WO2008030744A3 (en) Inhibitors of c-met and uses thereof
WO2010057101A3 (en) Compounds useful as hiv blockers
WO2007097931A3 (en) Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
WO2007136603A3 (en) Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
WO2012117000A8 (en) 3-amino-pyridines as gpbar1 agonists
EA201390198A1 (ru) Гетероциклическое соединение
MX2009004746A (es) Derivados de 1,2,4-triazol como inhibidores del receptor sigma.
BR112012009214A2 (pt) compostos
HK1215579A1 (zh) 被取代的2，3-二氫苯並呋喃基化合物和其用途
WO2010147830A3 (en) Aminothiazole modulators of beta-3-adrenoreceptor
WO2011006935A3 (en) Tetrazole derivatives
PH12014502448A1 (en) Pharmaceutical combinations for the treatment of metabolic disorders
WO2008079610A3 (en) Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome
NZ599171A (en) Sulfonamides for the prevention of diabetes
WO2009040314A3 (de) Neue heteroarylsubstituierte acetonderivate, geeignet zur hemmung der phospholipase a2
WO2009130422A3 (fr) N-acylthiourees et n-acylurees inhibiteurs de la voie de signalisation des proteines hedgehog

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 06 OCT 2015 BY SCAI S.R.L.

Effective date: 20141028

ASS Change of ownership

Owner name: DOMPE FARMACEUTICI S.P.A., IT

Effective date: 20151015

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 06 OCT 2016 BY SCAI S.R.L.

Effective date: 20151002

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 06 OCT 2017 BY COMPUTER PACKAGES INC

Effective date: 20160920

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 06 OCT 2018 BY COMPUTER PACKAGES INC

Effective date: 20170920

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 06 OCT 2019 BY COMPUTER PACKAGES INC

Effective date: 20180918

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 06 OCT 2020 BY COMPUTER PACKAGES INC

Effective date: 20190918

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 06 OCT 2021 BY COMPUTER PACKAGES INC

Effective date: 20200918

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 06 OCT 2022 BY COMPUTER PACKAGES INC

Effective date: 20210917

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 06 OCT 2023 BY COMPUTER PACKAGES INC

Effective date: 20220917

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 06 OCT 2024 BY COMPUTER PACKAGES INC

Effective date: 20230917

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 06 OCT 2025 BY COMPUTER PACKAGES INC

Effective date: 20240917

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 06 OCT 2026 BY COMPUTER PACKAGES INC

Effective date: 20250917